Lunai Bioworks Inc (RENB)

Currency in USD
0.238
-0.016(-6.31%)
Closed·
0.243+0.005(+1.97%)
·
RENB Scorecard
Full Analysis
Quickly burning through cash
RENB is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.2370.264
52 wk Range
0.2202.100
Key Statistics
Prev. Close
0.254
Open
0.26
Day's Range
0.237-0.264
52 wk Range
0.22-2.1
Volume
726.05K
Average Volume (3m)
3.32M
1-Year Change
-63.68%
Book Value / Share
0.56
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
RENB Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Lunai Bioworks Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Lunai Bioworks Inc Company Profile

Lunai Bioworks Inc., a pre-clinical stage biotechnology company, engages in the development of pharmaceutical and biological products for the treatment of cancer and HIV in the United States and the Netherlands. It operates through two segments, RENB and RENC. The company is developing a genetically modified allogeneic dendritic cell therapeutic vaccines, including RENB-DC11 to treat solid tumors primarily for pancreatic tumors; and RENB-DC20 for the treatment of breast cancer. It also develops an artificial intelligence platform technology for early cancer detection and its recurrence that uses a multi-omics approach to search for individual biomarkers that are present even in asymptomatic patients. The company has a strategic collaboration with Nebul to advance the early detection of cancer and other diseases. The company was formerly known as Renovaro Inc. and changed its name to Lunai Bioworks Inc. in August 2025. Lunai Bioworks Inc. is headquartered in Los Angeles, California.

Compare RENB to Peers and Sector

Metrics to compare
RENB
Peers
Sector
Relationship
P/E Ratio
−0.9x−2.7x−0.5x
PEG Ratio
−0.010.030.00
Price/Book
0.6x2.2x2.6x
Price / LTM Sales
-132.5x3.3x
Upside (Analyst Target)
-176.2%38.9%
Fair Value Upside
Unlock6.6%5.4%Unlock

Earnings

Latest Release
May 15, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

RENB Income Statement

People Also Watch

18.20
SRPT
-0.76%
0.048
TNFA
-21.10%
2.03
INMB
-2.87%
0.095
WINT
-1.04%
5.40
REPL
+0.37%

FAQ

What Stock Exchange Does Lunai Bioworks Trade On?

Lunai Bioworks is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Lunai Bioworks?

The stock symbol for Lunai Bioworks is "RENB."

What Is the Lunai Bioworks Market Cap?

As of today, Lunai Bioworks market cap is 54.96M.

What Is Lunai Bioworks's Earnings Per Share (TTM)?

The Lunai Bioworks EPS (TTM) is -0.38.

From a Technical Analysis Perspective, Is RENB a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Lunai Bioworks Stock Split?

Lunai Bioworks has split 0 times.

How Many Employees Does Lunai Bioworks Have?

Lunai Bioworks has 25 employees.

What is the current trading status of Lunai Bioworks (RENB)?

As of 30 Aug 2025, Lunai Bioworks (RENB) is trading at a price of 0.238, with a previous close of 0.25. The stock has fluctuated within a day range of 0.237 to 0.264, while its 52-week range spans from 0.220 to 2.100.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.